A GP guide to colchicine in coronary artery disease
Cheap, effective, widely available and easy to use — colchicine is an ideal adjunctive pharmacotherapy for some patients with coronary artery disease
Despite advances in medicine, cardiovascular disease remains a leading cause of morbidity and mortality within Australia.1
Patients with known coronary artery disease (CAD) have a high residual risk of subsequent major adverse cardiovascular events (MACE) compared to the general population, even when they have reached contemporary lipid-lowering targets and are adherent to antithrombotic therapy.
